StockStorm.ai

DexCom, Inc.

DXCM Stock News

Latest DXCM news

Dexcom Appoints Glenn Boehnlein to Board of Directors

Business Wire · Thu, 10 Sep 2026 16:15:00 -0400

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Glenn Boehnlein to its Board of Directors, effective September 10, 2026. Mr. Boehnlein is a highly accomplished healthcare executive and finance leader with more than 20 years of experience in the medical technology industry. Most recently, he served as Vice President and Chief Financial Officer of Stryker Corporation, one of the world's leading medical technology.

Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

PRNewsWire · Mon, 07 Sep 2026 15:27:00 -0400

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Market information is provided for research and visualization and is not investment advice.